litlas
Log inCreate account

Richard E. Royal

Active 1995–2021

40
Papers
18,026
Citations
39
h-index
40
i10-index

Citations

Citations per year for Richard E. Royal1993: 1 citations1996: 1 citations1997: 9 citations1998: 19 citations1999: 29 citations2000: 32 citations2001: 13 citations2002: 18 citations2003: 11 citations2004: 11 citations2005: 18 citations2006: 74 citations2007: 163 citations2008: 225 citations2009: 212 citations2010: 293 citations2011: 218 citations2012: 235 citations2013: 286 citations2014: 205 citations2015: 283 citations2016: 261 citations2017: 267 citations2018: 264 citations2019: 667 citations2020: 688 citations2021: 606 citations2022: 425 citations2023: 299 citations2024: 426 citations2025: 189 citations2026: 4 citations1994–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,625 citing papers, 36.4% of this breakdownChina: 547 citing papers, 7.6% of this breakdownGermany: 441 citing papers, 6.1% of this breakdownUnited Kingdom: 382 citing papers, 5.3% of this breakdownItaly: 343 citing papers, 4.8% of this breakdownNetherlands: 305 citing papers, 4.2% of this breakdownFrance: 303 citing papers, 4.2% of this breakdownAustralia: 235 citing papers, 3.3% of this breakdownJapan: 192 citing papers, 2.7% of this breakdownSwitzerland: 189 citing papers, 2.6% of this breakdownCanada: 159 citing papers, 2.2% of this breakdownSpain: 151 citing papers, 2.1% of this breakdown
0%36.4%Other 18.5%

Institutions

Fields

  • Medicine71.6%
  • Immunology and Microbiology17.4%
  • Biochemistry, Genetics and Molecular Biology9.4%
  • Engineering0.7%
  • Neuroscience0.2%
  • Mathematics0.1%
  • Other0.6%

Topics

  • Cancer Immunotherapy and Biomarkers14.9%
  • CAR-T cell therapy research13.2%
  • Immunotherapy and Immune Responses12.5%
  • Immune Cell Function and Interaction6.5%
  • Virus-based gene therapy research3.1%
  • Pancreatic and Hepatic Oncology Research2.9%
  • Other46.9%

Coauthors

All papers

Open in search
  1. Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma

    Authors: Richard E. Royal, Catherine Lévy, Keli Turner, Aarti Mathur, Marybeth S. Hughes, Udai S. Kammula, Richard M. Sherry, Suzanne L. Topalian, James C. Yang, Israel Lowy, Steven A. Rosenberg - Journal of Immunotherapy 2010 cited by 1,238

  2. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

    Authors: Rodabe N. Amaria, Sangeetha M. Reddy, Hussein A. Tawbi, Michael A. Davies, Merrick I. Ross, Isabella C. Glitza, Janice N. Cormier, Carol M. Lewis, Wen-Jen Hwu, Ehab Hanna, Adi Diab, Michael K. Wong, Richard E. Royal, Neil D. Gross, Randal S. Weber, Stephen Y. Lai, Richard A. Ehlers, Jorge Blando, Denái R. Milton, Scott E. Woodman, Robin Kageyama, Daniel K. Wells, Patrick Hwu, Sapna P. Patel, Anthony Lucci, Amy C. Hessel, Jeffrey E. Lee, Jeffrey E. Gershenwald, Lauren Simpson, Elizabeth M. Burton, Liberty Posada, Lauren E. Haydu, Linghua Wang, Shaojun Zhang, Alexander J. Lazar, Courtney W. Hudgens, Vancheswaran Gopalakrishnan, Alexandre Reuben, Miles C. Andrews, Christine N. Spencer, Víctor G. Prieto, Padmanee Sharma, James P. Allison, Michael T. Tetzlaff, Jennifer A. Wargo - Nature Medicine 2018 cited by 826

  3. Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

    Authors: Richard A. Morgan, Mark E. Dudley, John R. Wunderlich, Marybeth S. Hughes, James Chih‐Hsin Yang, Richard M. Sherry, Richard E. Royal, Suzanne L. Topalian, Udai S. Kammula, Nicholas P. Restifo, Zhili Zheng, Azam Nahvi, Christiaan R. de Vries, Linda Rogers-Freezer, Sharon Mavroukakis, Steven A. Rosenberg - Science 2006 cited by 2,586

  4. Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens

    Authors: Mark E. Dudley, James Chih‐Hsin Yang, Richard M. Sherry, Marybeth S. Hughes, Richard E. Royal, Udai S. Kammula, Paul F. Robbins, JianPing Huang, Deborah E. Citrin, Susan F. Leitman, John R. Wunderlich, Nicholas P. Restifo, Armen A. Thomasian, Stephanie G. Downey, Franz O. Smith, Jacob A. Klapper, Kathleen E. Morton, Carolyn M. Laurençot, Donald E. White, Steven A. Rosenberg - Journal of Clinical Oncology 2008 cited by 1,330

  5. Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

    Authors: Laura A. Johnson, Richard A. Morgan, Mark E. Dudley, Lydie Cassard, James C. Yang, Marybeth S. Hughes, Udai S. Kammula, Richard E. Royal, Richard M. Sherry, John R. Wunderlich, Chyi‐Chia Richard Lee, Nicholas P. Restifo, Susan Schwarz, Alexandria P. Cogdill, Rachel Bishop, Hung Kim, Carmen C. Brewer, Susan F. Rudy, Carter VanWaes, Jeremy L. Davis, Aarti Mathur, R. Taylor Ripley, Debbie Nathan, Carolyn M. Laurençot, Steven A. Rosenberg - Blood 2009 cited by 1,406

  6. Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

    Authors: Mark E. Dudley, John R. Wunderlich, James Chih‐Hsin Yang, Richard M. Sherry, Suzanne L. Topalian, Nicholas P. Restifo, Richard E. Royal, Udai S. Kammula, D E White, Sharon Mavroukakis, Linda Rogers, Gerald Gracia, Stephanie A. Jones, David P. Mangiameli, Michelle M. Pelletier, Juan Gea‐Banacloche, Michael R. Robinson, David M. Berman, Armando Filie, Andrea Abati, Steven A. Rosenberg - Journal of Clinical Oncology 2005 cited by 1,628

  7. Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients

    Authors: Laszlo Radvanyi, Chantale Bernatchez, Minying Zhang, Patricia S. Fox, Priscilla Miller, Jessica Chacon, Richard Wu, Gregory Lizée, Sandy Mahoney, Gladys Alvarado, Michelle R. Glass, Valen E. Johnson, John D. McMannis, Elizabeth J. Shpall, Víctor G. Prieto, Nicholas Papadopoulos, Kevin Kim, Jade Homsi, Agop Y. Bedikian, Wen‐Jen Hwu, Sapna P. Patel, Merrick I. Ross, Jeffrey E. Lee, Jeffrey E. Gershenwald, Anthony Lucci, Richard E. Royal, Janice N. Cormier, Michael A. Davies, Rahmatu Mansaray, Orenthial J. Fulbright, Christopher Toth, Renjith Ramachandran, Seth Wardell, Audrey M. Gonzalez, Patrick Hwu - Clinical Cancer Research 2012 cited by 433

  8. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial

    Authors: Rodabe N. Amaria, Peter A. Prieto, Michael T. Tetzlaff, Alexandre Reuben, Miles C. Andrews, Merrick I Ross, Isabella C. Glitza, Janice N. Cormier, Wen‐Jen Hwu, Hussein A. Tawbi, Sapna P. Patel, Jeffrey E. Lee, Jeffrey E. Gershenwald, Christine N. Spencer, Vancheswaran Gopalakrishnan, Roland L. Bassett, Lauren Simpson, Rosalind Mouton, Courtney W. Hudgens, Li Zhao, Haifeng Zhu, Zachary A. Cooper, Khalida Wani, Alexander J. Lazar, Patrick Hwu, Adi Diab, Michael K. Wong, Jennifer L. McQuade, Richard E. Royal, Anthony Lucci, Elizabeth M. Burton, Sangeetha M. Reddy, Padmanee Sharma, James P. Allison, Phillip Andrew Futreal, Scott E. Woodman, Michael A. Davies, Jennifer A. Wargo - The Lancet Oncology 2018 cited by 290

  9. Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome

    Authors: Marie‐Andrée Forget, Cara Haymaker, Kenneth R. Hess, Yuzhong Jeff Meng, Caitlin Creasy, Tatiana V. Karpinets, Orenthial J. Fulbright, Jason Roszik, Scott E. Woodman, Young Uk Kim, Donastas Sakellariou-Thompson, Ankit Bhatta, Arely Wahl, Esteban Flores, Shawne T. Thorsen, René J. Tavera, Renjith Ramachandran, Audrey M. Gonzalez, Christopher L. Toth, Seth Wardell, Rahmatu Mansaray, Vruti Patel, Destiny Joy Carpio, Carol Vaughn, Chantell M. Farinas, Portia G. Velasquez, Wen-Jen Hwu, Sapna P. Patel, Michael A. Davies, Adi Diab, Isabella C. Glitza, Hussein A. Tawbi, Michael K. Wong, Suzanne Cain, Merrick I. Ross, Jeffrey E. Lee, Jeffrey E. Gershenwald, Anthony Lucci, Richard E. Royal, Janice N. Cormier, Jennifer A. Wargo, Laszlo Radvanyi, Carlos A. Torres‐Cabala, Rameen Beroukhim, Patrick Hwu, Rodabe N. Amaria, Chantale Bernatchez - Clinical Cancer Research 2018 cited by 135

  10. Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4

    Authors: Kimberly E Beck, Joseph Blansfield, Khoi Q. Tran, Andrew L. Feldman, Marybeth S. Hughes, Richard E. Royal, Udai S. Kammula, Suzanne L. Topalian, Richard M. Sherry, David E. Kleiner, Martha Quezado, Israel Lowy, Michael Yellin, Steven A. Rosenberg, James Chih‐Hsin Yang - Journal of Clinical Oncology 2006 cited by 834

  11. High‐dose interleukin‐2 for the treatment of metastatic renal cell carcinoma

    Authors: Jacob A. Klapper, Stephanie G. Downey, Franz O. Smith, James Chih‐Hsin Yang, Marybeth S. Hughes, Udai S. Kammula, Richard M. Sherry, Richard E. Royal, Seth M. Steinberg, Steven A. Rosenberg - Cancer 2008 cited by 421

  12. Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4

    Authors: Peter Attia, Giao Q. Phan, Ajay V. Maker, Michael R. Robinson, Martha Quezado, James Chih‐Hsin Yang, Richard M. Sherry, Suzanne L. Topalian, Udai S. Kammula, Richard E. Royal, Nicholas P. Restifo, Leah Haworth, Catherine Lévy, Sharon Mavroukakis, Geoff Nichol, Michael Yellin, Steven A. Rosenberg - Journal of Clinical Oncology 2005 cited by 1,013

  13. Prognostic Factors Related to Clinical Response in Patients with Metastatic Melanoma Treated by CTL-Associated Antigen-4 Blockade

    Authors: Stephanie G. Downey, Jacob A. Klapper, Franz O. Smith, James Chih‐Hsin Yang, Richard M. Sherry, Richard E. Royal, Udai S. Kammula, Marybeth S. Hughes, Tamika Allen, Catherine Lévy, Michael Yellin, Geoffrey Nichol, Donald E. White, Seth M. Steinberg, Steven A. Rosenberg - Clinical Cancer Research 2007 cited by 626

  14. Contemporary Diagnostic Imaging Modalities for the Staging and Surveillance of Melanoma Patients: a Meta-analysis

    Authors: Y. Xing, Yulia Bronstein, M. I. Ross, Robert L. Askew, J. E. Lee, Jeffrey E. Gershenwald, Richard E. Royal, J. N. Cormier - JNCI Journal of the National Cancer Institute 2010 cited by 349

  15. Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis

    Authors: James Chih‐Hsin Yang, Marybeth S. Hughes, Udai S. Kammula, Richard E. Royal, Richard M. Sherry, Suzanne L. Topalian, Kimberly B. Suri, Catherine Lévy, Tamika Allen, Sharon Mavroukakis, Israel Lowy, Donald E. White, Steven A. Rosenberg - Journal of Immunotherapy 2007 cited by 695

  16. Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases

    Authors: Marybeth S. Hughes, Jonathan S. Zager, Mark B. Faries, H. Richard Alexander, Richard E. Royal, Bradford J. Wood, Junsung Choi, Kevin McCluskey, Eric D. Whitman, Sanjiv S. Agarwala, Gary P. Siskin, Charles Nutting, Mary Ann Toomey, Carole C. Webb, Tatiana Beresnev, James F. Pingpank - Annals of Surgical Oncology 2015 cited by 153

  17. Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma

    Authors: Kanwal Raghav, Suyu Liu, Michael J. Overman, Anneleis F. Willett, Mark Knafl, Szu-Chin Fu, Anaís Malpica, Seema Prasad, Richard E. Royal, Christopher P. Scally, Paul F. Mansfield, Ignacio I. Wistuba, P. Andrew Futreal, Dipen M. Maru, Luisa M. Solis Soto, Edwin R. Parra, Honglei Chen, Pamela Villalobos, Anuj Verma, Armeen Mahvash, Patrick Hwu, Patricia Cortazar, Edward McKenna, Cindy Yun, Shannon Dervin, Katja Schulze, Walter C. Darbonne, Ajaykumar C. Morani, Scott Kopetz, Keith F. Fournier, Scott E. Woodman, James C. Yao, Gauri R. Varadhachary, Daniel M. Halperin - Cancer Discovery 2021 cited by 73

  18. Circulating Tumor Cells and Early Relapse in Node-positive Melanoma

    Authors: Anthony Lucci, Carolyn Hall, Sapna P. Patel, Boomadevi Narendran, Jessica B. Bauldry, Richard E. Royal, Mandar Karhade, Joshua Upshaw, Jennifer A. Wargo, Isabella C. Glitza, Michael K. Wong, Rodabe N. Amaria, Hussein A. Tawbi, Adi Diab, Michael A. Davies, Jeffrey E. Gershenwald, Jeffrey E. Lee, Patrick Hwu, Merrick I. Ross - Clinical Cancer Research 2020 cited by 66

  19. Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Carcinomatosis or Positive Peritoneal Cytology in Patients with Gastric Adenocarcinoma

    Authors: Brian D. Badgwell, Mariela A. Blum, Prajnan Das, Jeannelyn S. Estrella, Xuemei Wang, Linus Ho, Keith F. Fournier, Richard E. Royal, Paul Mansfield, Jaffer A. Ajani - Annals of Surgical Oncology 2017 cited by 115

  20. Treatment of Metastatic Melanoma Using Interleukin-2 Alone or in Conjunction with Vaccines

    Authors: Franz O. Smith, Stephanie G. Downey, Jacob A. Klapper, James C. Yang, Richard M. Sherry, Richard E. Royal, Udai S. Kammula, Marybeth S. Hughes, Nicholas P. Restifo, Catherine Lévy, Donald E. White, Seth M. Steinberg, Steven A. Rosenberg - Clinical Cancer Research 2008 cited by 237

  21. Tumor Progression Can Occur despite the Induction of Very High Levels of Self/Tumor Antigen-Specific CD8+ T Cells in Patients with Melanoma

    Authors: Steven A. Rosenberg, Richard M. Sherry, Kathleen E. Morton, William J. Scharfman, James Chih‐Hsin Yang, Suzanne L. Topalian, Richard E. Royal, Udai S. Kammula, Nicholas P. Restifo, Marybeth S. Hughes, Douglas J. Schwartzentruber, David M. Berman, Susan Schwarz, Lien T. Ngo, Sharon Mavroukakis, Donald E. White, Seth M. Steinberg - The Journal of Immunology 2005 cited by 457

  22. Cytotoxic T-Lymphocyte-Associated Antigen-4 Blockage Can Induce Autoimmune Hypophysitis in Patients With Metastatic Melanoma and Renal Cancer

    Authors: Joseph Blansfield, Kimberly E Beck, Khoi Tran, James Chih‐Hsin Yang, Marybeth S. Hughes, Udai S. Kammula, Richard E. Royal, Suzanne L. Topalian, Leah Haworth, Catherine Lévy, Steven A. Rosenberg, Richard M. Sherry - Journal of Immunotherapy 2005 cited by 358

  23. Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma

    Authors: H. Richard Alexander, David L. Bartlett, James F. Pingpank, Steven K. Libutti, Richard E. Royal, Marybeth S. Hughes, Matthew P. Holtzman, Nader Hanna, Keli Turner, Tatiana Beresneva, Yue Zhu - Surgery 2013 cited by 150

  24. Improving the AJCC/TNM Staging for Adenocarcinomas of the Appendix

    Authors: Michael J. Overman, Keith F. Fournier, Chung-Yuan Hu, Cathy Eng, Melissa W. Taggart, Richard E. Royal, Paul Mansfield, George J. Chang - Annals of Surgery 2012 cited by 110